Solazyme and Space NK Sign UK Distribution Agreement for Anti-Aging Skincare line Algenist
Multi-channel distribution now spans nearly 1,000 retail locations worldwide
South San Francisco – July 28, 2011–Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, has signed a distribution agreement with the United Kingdom’s most innovative beauty retailer, Space NK, to expand the sales network of the company’s luxury skincare line, Algenist™, to include all 60 Space NK stores throughout the country. The advanced skincare brand, which features the breakthrough anti-aging ingredient, alguronic acid, will launch in Space NK stores and online beginning July 2011, retailing between £52 and £76.
Algenist is the world’s first skincare line to introduce the breakthrough anti-aging ingredient, alguronic acid to the market. In March of 2011, Solazyme successfully launched the initial Algenist product portfolio worldwide, in which it debuted to impressive results. In clinical trials, alguronic acid demonstrated superior anti-aging benefits and outperformed a multitude of highly successful regenerative compounds including hyaluronic acid and retinol.
“The Algenist brand has galvanized the skin and personal care space by placing biotechnology at the forefront of cosmetic innovation,” said Frederic Stoeckel, Senior Vice President & General Manager, Solazyme Health Sciences. “Algenist has defined an entirely new category of anti-aging skincare products, which compliment Space NK’s goal of offering selective, high quality, and effective beauty lines from exclusive brands around the world.”
“We are very excited to announce the launch of Algenist exclusively at Space NK stores,” said Nicky Kinnaird, Space NK, Founder. “This innovative skincare line, showcasing breakthrough anti-aging ingredient alguronic acid, fits perfectly within Space NK’s brand portfolio, and we anticipate as high a demand and success as Algenist has enjoyed since its launch in the United States.”
Algenist will launch in the UK with four initial product offerings featuring the advanced anti-aging ingredient alguronic acid. The Algenist Concentrated Reconstructing Serum, formulated with alguronic acid, helps to restore skin density and elasticity, minimize the appearance of wrinkles, and boost skin radiance. The Algenist Regenerative Anti-Aging Moisturizer and Regenerative Anti-Aging Moisturizer with SPF 20 helps to nourish and moisturize skin, rebuild firmness, and minimize the appearance of fine lines and wrinkles. Lastly, the Algenist Complete Eye Renewal Balm helps to reduce signs of aging and fatigue, diminish puffiness and dark circles and firm skin while minimizing fine lines around the eye area.
Solazyme’s launch of Algenist in Space NK will bolster existing retailer offerings including Sephora International, Sephora USA, Sephora Canada, QVC and The Shopping Channel.
About Solazyme, Inc.
Solazyme, Inc. (NASDAQ: SZYM) is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value oils. Headquartered in South San Francisco, Solazyme’s renewable products can replace or enhance oils derived from the world’s three existing sources – petroleum, plants and animal fats. Initially, Solazyme is focused on commercializing its products into three target markets: (1) fuels and chemicals, (2) nutrition and (3) skin and personal care.
Solazyme®, the Solazyme logo and other trademarks or service names are trademarks of Solazyme, Inc.
This press release contains certain forward-looking statements about Solazyme, including statements that involve risks and uncertainties concerning the launch of Algenist in the UK. When used in this press release, the words “will”, “expects”, “intends” and other similar expressions and any other statements that are not historical facts are intended to identify those assertions as forward-looking statements. Any such statement may be influenced by a variety of factors, many of which are beyond the control of Solazyme, that could cause actual outcomes and results to be materially different from those projected, described, expressed or implied in this press release due to a number of risks and uncertainties. Potential risks and uncertainties include, among others: Solazyme’s limited operating history; and its limited experience in the commercialization of its products. Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on the results of operations or financial condition of Solazyme.
In addition, please refer to the documents that Solazyme, Inc. files with the Securities and Exchange Commission, including its Registration Statement on Form S-1, for a discussion of these and other risks. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this press release. Solazyme is not under any duty to update any of the information in this press release
About Space NK:
In 1993, beauty entrepreneur Nicky Kinnaird founded the luxe beauty boutique SPACE.NK.apothecary. What began as a single store in Covent Garden, showcasing Kinnaird’s personal selection of beauty discoveries from around the globe, soon became the destination for the world’s most sought-after cult products and beauty solutions. Today, Space NK has grown to include 60 stores in the United Kingdom (including five shops within Harvey Nichols) and 20 stores in the United States (including 14 shops within Bloomingdale’s).
SPACE.NK.apothecary sources a carefully edited selection of the most innovative and top performing beauty products from the most creative, inspired and respected minds and iconic brands in beauty.